1. |
Tang ZY, Ye SL, Liu YK, et al. A decade’s studies on metastasis of hepatocellular carcinoma [J]. J Cancer Res Clin Oncol, 2004; 130(4)∶187.
|
2. |
Yamanaka N, Okamoto E, Fujihara S, et al. Do the tumor cells of hepatocellular carcinomas dislodge into the portal venous stream during hepatic resection? [J]. Cancer, 1992; 70(9)∶2263.
|
3. |
Jeng KS, Sheen IS, Tsai YC. Does the presence of circulating hepatocellular carcinoma cells indicate a risk of recurrence after resection? [J]. Am J Gastroenterol, 2004; 99(8)∶1503.
|
4. |
Waguri N, Suda T, Nomoto M, et al. Sensitive and specific detection of circulating cancer cells in patients with hepatocellular carcinoma; detection of human telomerase reverse transcriptase messenger RNA after immunomagnetic separation [J]. Clin Cancer Res, 2003; 9(8)∶3004.
|
5. |
Carr BI. An assay for micrometastatic hepatocellular carcinoma [J]. Gastroenterology, 1994; 106(1)∶264.
|
6. |
Reid AE, Liang TJ. Tumor marker for metastasis: searching for an abnormal needle in a haystack [J]. Hepatology, 1994; 20(6)∶1631.
|
7. |
Koo J, Fung K, Siu KF, et al. Recovery of malignant tumor cells from the right atrium during hepatic resection for hepatocellular carcinoma [J]. Cancer, 1983; 52(10)∶1952.
|
8. |
Leonhardt U, Ritzel U, Ottleben M, et al. Circulating human hepatic lipase mRNA in patients with hepatocellular carcinoma and healthy controls [J]. Eur J Surg, 1999; 165(6)∶539.
|
9. |
Kar S, Carr BI. Detection of liver cells in peripheral blood of patients with advanced-stage hepatocellular carcinoma [J]. Hepatology, 1995; 21(2)∶403.
|
10. |
Dodd GD 3rd, Carr BI. Percutaneous biopsy of portal vein th-rombus: a new staging technique for hepatocellular carcinoma [J]. AJR Am J Roentgenol, 1993; 161(2)∶229.
|
11. |
Vilana R, Bru C, Bruix J, et al. Fine-needle aspiration biopsy of portal vein thrombus: value in detecting malignant thrombosis [J]. AJR Am J Roentgenol, 1993; 160(6)∶1285.
|
12. |
Fujimoto K, Nakamura K, Takashima S, et al. Angioscopy of the inferior vena cava: preliminary observations in cases with involvement by neoplasm. Work in progress [J]. J Vasc Interv Radiol, 1991; 2(3)∶371.
|
13. |
Wong IH, Lo YM, Yeo W, et al. Frequent p15 promoter me-thylation in tumor and peripheral blood from hepatocellular carcinoma patients [J]. Clin Cancer Res, 2000; 6(9)∶3516.
|
14. |
Komeda T, Fukuda Y, Sando T, et al. Sensitive detection of circulating hepatocellular carcinoma cells in peripheral venous blood [J]. Cancer, 1995; 75(9)∶2214.
|
15. |
Sabile A, Louha M, Bonte E, et al. Efficiency of Ber-EP4 antibody for isolating circulating epithelial tumor cells before RT-PCR detection [J]. Am J Clin Pathol, 1999; 112(2)∶171.
|
16. |
Vona G, Sabile A, Louha M, et al. Isolation by size of epithelial tumor cells: a new method for the immunomorphological and molecular characterization of circulatingtumor cells [J]. Am J Pathol, 2000; 156(1)∶57.
|
17. |
Rostagno P, Moll JL, Bisconte JC, et al. Detection of rare circulating breast cancer cells by filtration cytometry and identification by DNA content: sensitivity in an experimental model [J]. Anticancer Res, 1997; 17(4A)∶2481.
|
18. |
Ito A, Shinkai M, Honda H, et al. Medical application of functionalized magnetic nanoparticles [J]. J Biosci Bioengin, 2005; 100(1)∶1.
|
19. |
Jiang SY, Shyu RY, Huang MF, et al. Detection of alphafetoprotein-expressing cells in the blood of patients with hepatoma and hepatitis [J]. Br J Cancer, 1997; 75(6)∶928.
|
20. |
Funaki N, Tanaka J, Seto S, et al. Highly-sensitive identification of alpha-fetoprotein mRNA in circulating peripheral blood of hepatocellular carcinoma patients [J]. Life Sci, 1995; 57(17)∶1621.
|
21. |
Matsumura M, Niwa Y, Hikiba Y, et al. Sensitive assay for detection of hepatocellular carcinoma associated gene transcription (alpha-fetoprotein mRNA) in blood [J]. Biochem Biophys Res Commun, 1995; 207(2)∶813.
|
22. |
Chou HC, Sheu JC, Huang GT, et al. Albumin messenger RNA is not specific for circulating hepatoma cells [J]. Gastroenterology, 1994; 107(2)∶630.
|
23. |
Kienle P, Weitz J, Klaes R, et al. Detection of isolated disseminated tumor cells in bone marrow and blood samples of patients with hepatocellular carcinoma [J]. Arch Surg, 2000; 135(2)∶213.
|
24. |
Gross-Goupil M, Saffroy R, Azoulay D, et al. Real-time quantification of AFP mRNA to assess hematogenous dissemination after transarterial chemoembolization of hepatocellular carcinoma [J]. Ann Surg, 2003; 238(2)∶241.
|
25. |
Mou DC, Cai SL, Peng JR, et al. Evaluation of MAGE-1 and MAGE-3 as tumour-specific markers to detect blood dissemination of hepatocellular carcinoma cells [J]. Br J Cancer, 2002; 86(1)∶110.
|
26. |
Fujiwara Y, Sugita Y, Nakamori S, et al. Assessment of Stanniocalcin-1 mRNA as a molecular marker for micrometastases of various human cancers [J]. Int J Oncol, 2000; 16(4)∶799.
|
27. |
Matsumura M, Niwa Y, Kato N, et al. Detection of alpha-fetoprotein mRNA, an indicator of hematogenous spreading hepatocellular carcinoma, in the circulation: a possible predictor of metastatic hepatocellular carcinoma [J]. Hepatology, 1994; 20(6)∶1418.
|
28. |
Miyamoto A, Fujiwara Y, Sakon M, et al. Development of a multiple-marker RT-PCR assay for detection of micrometastases of hepatocellular carcinoma [J]. Dig Dis Sci, 2000; 45(7)∶1376.
|
29. |
Wong IH, Yeo W, Leung T, et al. Circulating tumor cell mRNAs in peripheral blood from hepatocellular carcinoma patients under radiotherapy, surgical resection or chemotherapy: a quantitative evaluation [J]. Cancer Lett, 2001; 167(2)∶183.
|
30. |
Chelly J, Concordet JP, Kaplan JC, et al. Illegitimate transcription: transcription of any gene in any cell type [J]. Proc Natl Acad Sci USA, 1989; 86(8)∶2617.
|
31. |
Aselmann H, Wolfes H, Rohde F, et al. Quantification of alpha 1-fetoprotein mRNA in peripheral blood and bone marrow: a tool for perioperative evaluation of patients with hepatocellular carcinoma [J]. Langenbecks Arch Surg, 2001; 386(2)∶118.
|
32. |
Nicoli N, Casaril A, Hilal MA, et al. A case of rapid intrahepatic dissemination of hepatocellular carcinoma after radiofrequency thermal ablation [J]. Am J Surg, 2004; 188(2)∶165.
|
33. |
Wu F, Wang ZB, Jin CB, et al. Circulating tumor cells in patients with solid malignancy treated by high-intensity focused ultrasound [J]. Ultrasound Med Biol, 2004; 30(4)∶511.
|